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Abstract Calpain, a Ca2+-dependent biomodulator, alters the
properties of substrate proteins by cleaving them at a limited
number of specific sites. Recent studies of the structure-function
relationship of calpain and X-ray analysis of its Ca2+-binding
domain have revealed hitherto unknown features of the regula-
tion of calpain activity. A novel dissociation/autolysis mechanism
for the activation of calpain at the membrane is proposed, which
incorporates recent findings from structure-function studies of
calpain, and its implications are discussed.
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1. Introduction
Calpain is a typical cytosolic cysteine protease that abso-
lutely requires Ca2 for activity [1^12]. It has attracted much
attention as a fundamentally important cellular modulator
implicated in a wide variety of biological phenomena related
to Ca2. It might also play a role in various pathological
states, including degenerative diseases of muscle and nerve,
apoptosis, hypertension, cataract formation, rheumatoid ar-
thritis, and Alzheimer’s disease [8,9]. Two forms, W- and m-
calpain, are expressed ubiquitously in animal tissues and have
been widely studied. Both are heterodimers, consisting of a
homologous catalytic 80 kDa subunit and the identical regu-
latory 30 kDa subunit made up of distinct domains (Fig. 1).
They are distinguished by the Ca2 concentration required for
in vitro activity: W-calpain requires WM levels of Ca2, while
m-calpain requires mM levels. Calpain cleaves target proteins
in a restricted manner to modify their properties rather than
digest the substrate proteins. Since calpain requires unphysio-
logically high Ca2 levels, the activation or sensitization of
calpain to Ca2 is required before in vivo activity occurs.
To answer the central question, What is the physiological
function of calpain? it is essential to understand the regula-
tory and activation mechanisms of calpain. In this paper, our
model for the activation of calpain is discussed, together with
several recent ¢ndings that are important for discussion of the
activation model.
2. Recent developments in the structure-function study of
calpain
Recent studies have identi¢ed many calpain isoforms, indi-
cating that calpain constitutes a large superfamily. The family
members can be classi¢ed as typical calpains, which are fur-
ther divided into ubiquitous and tissue-speci¢c calpains, or
atypical calpains (Fig. 1). Tissue-speci¢c calpains were only
recently discovered and their characterization as proteins
and enzymes is still incomplete, although they are apparently
more suitable than ubiquitous calpains to analyze the physio-
logical function of calpain. Atypical calpains have a protease
domain homologous to that found in the large subunit (CL,
domain II), but lack other calpain domains, including the
Ca2 binding domain (domain IV). The analysis of atypical
calpains, especially those from yeast and Aspergillus, should
provide important clues to determine the physiological func-
tion of calpain in animals, since gene manipulation is much
easier in these organisms [3].
The sequence identity of the protease domain (II) of calpain
homologues to other cysteine proteases, although restricted to
the immediate vicinity of the active site residues, suggests that II
should be active without Ca2. If this is the case, Ca2 is only
necessary for structural purposes and not for catalysis directly.
Various attempts to obtain an enzymatically active Ca2-inde-
pendent fragment, by autolysis or the digestion of calpain with
other proteases, have not been successful. However, a geneti-
cally engineered fragment expressed in Escherichia coli, which
consisted essentially of domains I, II, and III, showed Ca2-
independent activity corresponding to 44% of the original en-
zyme Ca2-dependent activity [13]. Thus, domain II, but not
IV, is necessary and su⁄cient for protease activity.
Quite recent results of the X-ray structural analysis of the
Ca2-binding domain (IVP) of the small subunit (CS) revealed
¢ve Ca2-binding EF-hand motifs, rather than the four pre-
dicted from the sequence of IVP [14,15]. The presence of the
most N-terminal EF-hand motif could not be predicted from
the sequence. Furthermore, the ¢fth most C-terminal EF-hand
motif does not bind Ca2 but interacts with its counterpart in
a second molecule, resulting in homodimer formation. These
results suggest a novel model for the association of the two
calpain subunits, in which the ¢fth EF-hand motifs in IV and
IVP interact with each other. In agreement with this model,
calpain loses its activity and the ability to form a complex
when 8^10 amino acid residues from the C-terminus of both
subunits are cleaved by carboxypeptidase [16]. Studies of ex-
pressed mutants also indicated that removal of 22^25 C-ter-
minal residues from IVP eliminated the reconstitution ability
of active calpain [17]. Thus, the ¢fth EF-hand motif in CL
and CS is responsible for both heterodimer and homodimer
formation.
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3. Necessity of calpain activation
The Ca2 concentrations required for half-maximal activity
of calpain (Ka) measured in vitro usually range from 5^50 WM
for W-calpain, and 200^1000 WM for m-calpain. Nevertheless,
both calpains seem to be active at physiological Ca2 concen-
trations of 100^300 nM, suggesting that more than Ca2
alone is required for calpain activity in vivo. In fact, activator
proteins and factors that increase the Ca2 sensitivity of cal-
pain have been described. Most recently, an activator protein
speci¢c for W-calpain, isolated from rat brain, was sequenced
[18]. This activator is a Ca2-binding protein that forms a 1:1
complex with W-calpain, but not with m-calpain, and increases
its Ca2 sensitivity 10 fold without a¡ecting the Vmax value.
Another activator speci¢c for m-calpain is found in skeletal
muscle. It also forms a 1:1 complex with m-calpain and low-
ers the Ka value from 400 WM to 15 WM by facilitating auto-
lysis [19]. These two activators bind to the membrane in a
Ca2-dependent manner, suggesting that they function on
the membrane.
Phospholipids, especially acidic phospholipids, greatly re-
duce the Ca2 concentration necessary for autolysis and
thus for activity [20,21]. In their presence, W-calpain becomes
fully active at WM or lower Ca2 concentrations, whereas
phospholipids are insu⁄cient to activate m-calpain at physio-
logical Ca2 concentrations. Although some other activators
and factors including DNA have been reported [22], their
nature and physiological implications and the mechanism of
activation are still very poorly understood.
Autolysis, which modi¢es the N-terminal regions of both
subunits, increases the Ca2-sensitivity of calpain signi¢cantly
[2,23]. While it is quite clear that autolysis lowers the Ka value
of both W- and m-calpain, a critical problem in autolytic acti-
vation is that a higher Ca2 concentration is required to ini-
tiate autolysis [24]. The calpain cascade, in which W-calpain
activates m-calpain at near WM levels of Ca2, is interesting
but inconsistent with previous ¢ndings [24]. Arguments still
remain over how autolysis occurs in vivo and whether auto-
lysis is necessary to raise Ca2 sensitivity or for calpain activ-
ity. Molinari et al. reported the hydrolysis of Ca2-ATPase
and band 3 protein when calpain remains intact [25]. It should
be mentioned that the autolysed forms of W-calpain show
distinct substrate speci¢cities [26]. To summarize the recent
results, autolysis does not seem to be necessary for the ex-
pression of protease activity, but it has an important e¡ect on
the dissociation and thus the activation of calpain.
4. Dissociation and activation
Dissociation and reassociation studies of calpain have re-
vealed that calpain dissociates into subunits in the presence of
Ca2 and that the dissociated CL retains full enzymatic activ-
ity [27,28]. Studies of the expression of CL have indicated that
it is fully active without the co-expression of CS [13,29]. In
most cases, CL expressed without CS forms a homodimer. In
some cases, however, CL seems to exist as a monomer. CL
and CS, and thus IV and IVP, are unstable and tend to form
aggregates, but become stable after dimer formation. CL and
CS will form homodimers, at least when only one is present.
CL is fully active enzymatically whether or not it forms a
dimer. Taken together, the dissociation of calpain into sub-
units implies its activation and dissociated CL should be re-
garded as an active species in vivo. However, the enzymatic
characterization of CL as an active species in vivo is inad-
equate and the exact Ca2 concentration required for dissoci-
ation has not yet been determined.
The autolysis of calpain only modi¢es the N-terminal re-
gion of both subunits. Our unpublished results indicate that
removal of the N-terminal region of CL, but not of CS, facil-
itates the dissociation of calpain into subunits. Assuming that
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Fig. 1. Some typical members of the calpain superfamily.
K. Suzuki, H. Sorimachi/FEBS Letters 433 (1998) 1^42
CL is an active species, the previous results of autolysis stud-
ies, which show that the N-terminal modi¢cation enhances the
Ca2 sensitivity of calpain, can be interpreted in terms of the
dissociation of N-terminally modi¢ed CL from CS [28]. Dis-
sociation could be a consequence of autolysis. Since dissoci-
ated intact CL is fully active, however, autolysis is not a pre-
requisite for activation. Autolysis is important for activation
in terms of dissociation, but it is not su⁄cient. Rather, true
activation requires dissociation into subunits.
Our model for the activation of calpain, which combines
the results of dissociation studies with a previous membrane
activation theory, is summarized in Fig. 2. Calpain translo-
cates to the membrane when it binds to Ca2. This induces
conformational changes in calpain and exposes hydrophobic
regions, probably ascribed to IV and IVP on the surface of the
molecule. The Ca2 concentrations required for the conforma-
tional changes are signi¢cantly lower than those required for
its dissociation into subunits and the expression of activity.
On biological membranes, the dissociation of calpain into
subunits occurs in the presence of Ca2, membrane phospho-
lipids, or activator(s). Membrane phospholipids decrease the
Ca2 concentration required for autolysis, resulting in the
modi¢cation of CL, which eventually causes the dissociation
of W-calpain under physiological conditions. Dissociated CL
hydrolyzes substrates, either at the membrane or after its lib-
eration into the cytosol. The model has another advantage;
dissociation into subunits might facilitate the release of dis-
sociated CL from the membrane. Indeed, autolysed CL is
found only in the cytosol [30]. The mechanism for the disso-
ciation of calpain into subunits without autolysis is currently
hypothetical and awaits further studies.
This dissociation model introduces an additional mechanis-
tic step for the activation of calpain, but the earlier controv-
ersy over Ca2 concentration still remains, at least as far as
m-calpain is concerned. In the case of m-calpain, none of the
conditions or factors reported so far activate m-calpain at
physiological Ca2 concentrations. Thus, a sophisticated
mechanism is probably essential for the autolysis and dissoci-
ation of m-calpain, which involves activators or factors that
signi¢cantly reduce the Ca2 requirement. Translocation to
the membrane might be one of the important steps necessary
to sequester calpain from its endogenous inhibitor, calpasta-
tin.
Tissue-speci¢c calpains, identi¢ed quite recently, appear to
exist by themselves and their counterpart proteins correspond-
ing to CS have not yet been identi¢ed. Their protein levels are
very low in contrast to their relatively high mRNA levels. The
dissociation mechanism suggests that tissue-speci¢c calpains
exist in an active dissociated form, resulting in a very low
protein level.
Dissociated CL or CS, or their autolysed forms, have not
yet been identi¢ed in vivo. The detection of dissociated CL or
CS, which should be possible by using speci¢c antibodies
raised against a dissociated single subunit, will provide clues
to answer important questions: where, how, and to what ex-
tent does the dissociation of calpain occur? Dissociation with-
out autolysis might be a reversible process, whereas autolysis-
involved dissociation should be irreversible. Recently identi-
¢ed homologues of CS are found as a dimer and have a
speci¢c function [31], suggesting that CS might also form a
dimer after its dissociation from CL, and have a function
distinct from protease activity. Likewise, the possibility that
CL also forms a homodimer after its dissociation from CS
also exists, but this is open to debate. The Ca2-induced dis-
sociation of calpain is observed with both W- and m-calpain.
Furthermore, our unpublished studies indicate that a homo-
dimer of IV and IVP formed in the absence of Ca2 dissociates
in the presence of Ca2, although the exact Ca2 concentra-
tion necessary for dissociation has not been determined.
There are, however, inconsistent results [17]. Both subunits
of W- and m-calpains are co-precipitated in Ca2 by mono-
clonal antibodies directed against a single subunit [32]. The X-
ray structural analysis of IVP suggests dimer formation both
in the presence and absence of Ca2 [14,15]. The fact that
dissociation occurs in Ca2 is very important [28,33], although
Ca2-induced aggregation makes conclusive experiments on
this point very di⁄cult. Apparently, more precise analysis of
the Ca2-induced dissociation is essential.
FEBS 20618 14-8-98
Fig. 2. Dissociation/autolysis mechanism for activation of calpain. For details see text.
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5. Perspectives
In this review, we brie£y summarize the current knowledge
of the structure and function of calpain and propose a novel
dissociation/autolysis mechanism for its activation at the
membrane. In order to unravel the physiological function of
calpain, knowledge of the activation mechanism is most im-
portant, as is understanding of the e¡ect of speci¢c calpain
inhibitors [12] and studies using antibodies speci¢c for certain
species of calpain during activation. It is hoped that the pro-
posed activation model stimulates discussion on the activation
mechanism, leading to understanding of the physiological
function of calpain.
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